Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States. [PDF]
Sullivan SD+3 more
europepmc +1 more source
Cost-effectiveness analysis of aducanumab versus placebo for patients with mild cognitive impairment and mild Alzheimer's disease. [PDF]
Xiong X+5 more
europepmc +1 more source
Cost-Effectiveness of Nirmatrelvir/Ritonavir in COVID-19 Patients at High-Risk for Progression in Spain. [PDF]
Azanza JR+10 more
europepmc +1 more source
Cost-effectiveness of novel diagnostic tools for idiopathic pulmonary fibrosis in the United States. [PDF]
Cadham CJ+3 more
europepmc +1 more source
Costs and cost-effectiveness of integrated screening for non-communicable diseases in TB contacts. [PDF]
Hamada Y+9 more
europepmc +1 more source
The Political Sociology of NICE: Investigating Pharmaceutical Cost-Effectiveness Regulation in the UK. [PDF]
Abraham J, Balendran G.
europepmc +1 more source
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome. [PDF]
van den Broek WWA+16 more
europepmc +1 more source
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults.
Hwang JH+3 more
europepmc +1 more source
Cost-Effectiveness of Functional Family Therapy for Youth Probationers in Singapore: Findings From a Randomized Controlled Trial. [PDF]
Fang L+6 more
europepmc +1 more source